| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 10/15/2009 | US20090258417 Culture Vessel and a Method of Culture |
| 10/15/2009 | US20090258396 Crustaceans as production systems for therapeutic proteins |
| 10/15/2009 | US20090258395 Irx-2 modified manufacturing process |
| 10/15/2009 | US20090258393 Single chain class i major histocompatibility complexes, constructs encoding same and methods of generating same |
| 10/15/2009 | US20090258391 Recombinant cell clones having increased stability and methods of making and using same |
| 10/15/2009 | US20090258380 Perhydrolase Epitopes |
| 10/15/2009 | US20090258363 Targeted integration and expression of exogenous nucleic acid sequences |
| 10/15/2009 | US20090258361 Variant tlr4 nucleic acid and uses thereof |
| 10/15/2009 | US20090258338 Simulated 5-part differential leukocyte granules, the method for preparing the same and control products and calibrators comprising the same |
| 10/15/2009 | US20090258337 Thawed organ or tissue or thawed cell group to be donated, transplanted, added, or administered to living body, production process thereof, supercooled solution therefor, and production apparatus of the organ or tissue |
| 10/15/2009 | US20090258092 Improved Tissue Maintenance |
| 10/15/2009 | US20090258031 fusion protein comprising polypeptide with a human immunoglobulin (Ig) polypeptide; has an ability to bind CD80 or CD86 or an extracellular domain of either CD80 or CD86, and/or an ability to inhibit a T cell immune response |
| 10/15/2009 | US20090258026 Anti-notch1 nrr antibodies and methods using same |
| 10/15/2009 | US20090258025 Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders |
| 10/15/2009 | US20090258022 protein comprising signal transduction domain for use in treatment and prevention of nervous system disorders; immunizing a mammal with a protein comprising the sequence of SEQ ID NO:2 |
| 10/15/2009 | US20090258020 Antibody designated barb3, barb3 related antibodies, and methods of making and using same |
| 10/15/2009 | US20090258013 Novel compositions and methods for the treatment of immune related diseases |
| 10/15/2009 | US20090258007 Anti-Perp Antibody |
| 10/15/2009 | US20090258005 Therapeutic compositions and methods |
| 10/15/2009 | US20090258002 Biomarkers for Tissue Status |
| 10/15/2009 | US20090257991 Engineering and Delivery of Therapeutic Compositions of Freshly Isolated Cells |
| 10/15/2009 | US20090257990 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 10/15/2009 | US20090257989 Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells |
| 10/15/2009 | US20090257988 Methods and compositions for accelerating the generation of regulatory t cells ex vivo |
| 10/15/2009 | US20090257987 Method of generating dopamine-secreting cells |
| 10/15/2009 | US20090257986 Epidermal and dermal equivalents |
| 10/15/2009 | US20090257985 Methods of regulating expression of genes or of gene products using substituted tetracycline compounds |
| 10/15/2009 | US20090257981 Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same |
| 10/15/2009 | US20090257952 Engineered Integrin Binding Peptides |
| 10/15/2009 | CA2721088A1 Methods and compositions for accelerating the generation of regulatory t cells ex vivo |
| 10/15/2009 | CA2720699A1 Detection and tratment of pancreatic, ovarian and other cancers |
| 10/15/2009 | CA2720610A1 Methods of recombinant production of glycoproteins |
| 10/15/2009 | CA2710398A1 Methods and compositions for targeting polyubiquitin |
| 10/14/2009 | EP2108696A1 Cis-acting diversification activator and method for selective diversification of nucleic acids |
| 10/14/2009 | EP2108044A2 Sub -population of hematopoietic stem cells that express the crisp-1 protein |
| 10/14/2009 | EP2108043A1 Novel methods and reagents directed to production of cells |
| 10/14/2009 | EP1881008A9 Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody |
| 10/14/2009 | EP1672063B1 Method of introducing nucleic acid |
| 10/14/2009 | EP1554572B1 Compositions and methods for modulating blood-brain barrier transport |
| 10/14/2009 | EP1517604B1 No-apical meristem proteins, polynucleotides and methods of use for same |
| 10/14/2009 | EP1488240B1 Detection of specific nitrated markers |
| 10/14/2009 | EP1360498B1 Latent human tuberculosis diagnostic antigen and method of use |
| 10/14/2009 | EP1356046B1 Cytokine receptor zcytor19 |
| 10/14/2009 | EP1331950B1 Ex vivo methods and compositions for nucleic acid delivery |
| 10/14/2009 | EP1313860B1 Butinol i esterase |
| 10/14/2009 | EP1230268B1 Heteroclitic analogs of class i epitopes |
| 10/14/2009 | EP1180686B1 Remedies for kidney diseases and method for screening the same |
| 10/14/2009 | EP1161548B2 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
| 10/14/2009 | EP1005481B1 Methods for the production of aslv reverse transcriptases composed of multiple subunits |
| 10/14/2009 | CN101558151A Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy |
| 10/14/2009 | CN101555488A Method for constructing recombinant retrovirus carrier with cell factor cDNA |
| 10/14/2009 | CN101555487A RNA interference carrier used for osteoporosis and rat mesenchymal stem cells |
| 10/14/2009 | CN101555481A Heat stable mutants of starch biosynthesis enzymes |
| 10/14/2009 | CN101555480A Vegetable starch synthetase genetic promoter and use thereof |
| 10/14/2009 | CN101555479A Moss expressing promoting regions |
| 10/14/2009 | CN101555472A Polypeptides having cellobiohydrolase ii activity and polynucleotides encoding same |
| 10/14/2009 | CN101555467A Method for preparing recombinant retrovirus incasing cell with interleukin-2 |
| 10/14/2009 | CN101555466A Sheep embryo in-vitro culture solution containing astragalus polysaccharide and culture method thereof |
| 10/14/2009 | CN101555453A Endothelial cell bioreactor as well as preparation method and application thereof |
| 10/14/2009 | CN101555282A Antibody of fucosylated Golgi protein GP73 and use thereof |
| 10/14/2009 | CN100549177C Agarase and gene thereof |
| 10/14/2009 | CN100549171C Polynucleotide for target gene |
| 10/14/2009 | CN100549163C Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same |
| 10/14/2009 | CN100549029C Plant disease resistance-related protein SGT1, and coding gene, and application |
| 10/14/2009 | CN100549028C Plant against disease relevant protein RAR1, and coding gene, and application |
| 10/14/2009 | CN100549021C Cynomolgus prostate specific antigen |
| 10/14/2009 | CN100548377C Vaccine composition containing modified dendritic cells |
| 10/14/2009 | CN100548105C Manufacture method for seed having a live end seal coating |
| 10/13/2009 | US7601900 Plants and seeds of corn variety cv076785 |
| 10/13/2009 | US7601897 Soybean variety XB48X07 |
| 10/13/2009 | US7601896 Soybean cultivar 2387029 |
| 10/13/2009 | US7601892 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 10/13/2009 | US7601891 Optimizing glycan processing of a plant cell containing glycoproteins with hybrid or complex type N-glycanscontaining a galactose residue on one arm of the N-glycan and which are devoid or reduced in xylose and fucose residues; genetic engineering; hybrid enzymes; drugs |
| 10/13/2009 | US7601889 Cucleic acid cotnaining a specific nucleotide sequence which encodes a polypeptide which elongates alpha -linolenic acid by two or more carbon atoms whereas gamma -lino-lenic is not elongated |
| 10/13/2009 | US7601888 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 10/13/2009 | US7601885 Transgenic plant comprising a cassava vein mosaic virus promoter and a heterologous nucleic acid sequence |
| 10/13/2009 | US7601884 In vitro development of a nuclear transfer embryo improved by treatment with demecolcine after activation using somatic cell nuclear transfer technology; maintenance of pregnancy improved; improved blastocyst development; enucleation; injection; fusion; activation |
| 10/13/2009 | US7601872 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 10/13/2009 | US7601829 for use in designing and/or identifying modulators of insect behavior; biolgical pest control |
| 10/13/2009 | US7601826 Genes and polypeptides relating to human pancreatic cancers |
| 10/13/2009 | US7601818 Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors |
| 10/13/2009 | US7601816 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity |
| 10/13/2009 | US7601813 Anti-GL50 antibodies |
| 10/13/2009 | US7601812 Schistosoma protein for use in treatment of organ-specific autoimmune diseases |
| 10/13/2009 | US7601809 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs |
| 10/13/2009 | US7601807 polypeptide has a proteolytic activity of cutting at a Gly-Phe site or a Ser-Leu site of a peptide or protein, for degrading heat-denatured collagens, gelatins to suitable molecular weight; encoded by a polynucleotide; friendly foods, cosmetics, pharmaceuticals, paints, and plastic materials |
| 10/13/2009 | US7601805 Photoprotein with improved bioluminescence |
| 10/13/2009 | US7601804 immunogens for treating cattle diseases; biodrugs for veterinary medicine |
| 10/13/2009 | US7601803 mutagenized bovine gamma-II-crystallin polypeptide with binding to the Hormone Estradiol; antibodies, enzymes |
| 10/13/2009 | US7601799 Methods and means to promote gut absorption |
| 10/13/2009 | US7601703 Complexing the target cell with therapeutic agent; antiproliferative agent |
| 10/13/2009 | US7601700 Modified antisense oligonucleotide; antitumor and anticancer agents |
| 10/13/2009 | US7601687 Drug screening for non-insulin dependent diabetes mellitus, beta cell dysfunction and peripheral insulin resistance |
| 10/13/2009 | US7601535 For in vitro cell culture which contain substantially saturated amounts of selected amino acids; improved exogenous gene expression; also extends cell longevity |
| 10/13/2009 | US7601534 Maintaining a non-differentiated state of human stem cells, while allowing cell division of said human stem cells |
| 10/13/2009 | US7601525 Alginate gel scaffold having a plurality of continuous parallel microtubular copper capillaries |
| 10/13/2009 | US7601516 Follicle stimulating hormone-immunoglobulin fusion fo use in treatment of reproductive disorders |
| 10/13/2009 | US7601514 Encodes a polypeptide which inhibits the proliferation of T-lymphocytes; use in diagnosis and treatment of immune disorders; PRO polypeptides; autoimmune disorders |
| 10/13/2009 | US7601508 Ecdysone receptor polypeptide from the homopteran whitefly (Bamecia argentifoli, BaEcR) use screening for monoclonal antibodies; biological insecticides |
| 10/13/2009 | US7601501 screening for agents that promote osteogenesis; use treating bone disorders, promote differentiation path of mesenchymal stem cells into osteoblasts for tissue engineering |